Researchers from Lund University in Sweden have identified distinct molecular signatures associated with the clinical signs of sepsis that could provide more accurate diagnosis and prognosis of sepsis, as well as help to target specific therapies at patients who would benefit most, according to new research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April).
For clinician-administered drugs, researchers find no association between price increases and OOP cost increases
It seems obvious to assume that patient out-of-pocket costs would increase as drug companies raise the prices of their drugs. But a new study published
January 23, 2024